The Global Health Observatory. Global health estimates 2020: deaths by cause, age, sex, by country and by region. 2000-2019 (WHO, 2020).
Bray, F. et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127, 3029–3030 (2021).
Meijers, R. A. & de Boer, R. A. Common risk factors for heart failure and cancer. Cardiovasc. Res. 115, 844–853 (2019).
Article CAS PubMed PubMed Central Google Scholar
de Boer, R. A. et al. Cancer and heart disease: associations and relations. Eur. J. Heart Fail. 21, 1515–1525 (2019).
Koene, R. J. et al. Shared risk factors in cardiovascular disease and cancer. Circulation 133, 1104–1114 (2016).
Article PubMed PubMed Central Google Scholar
Stoltzfus, K. C. et al. Fatal heart disease among cancer patients. Nat. Commun. 11, 2020 (2011).
Battisti, N. M. L. et al. Prevalence of cardiovascular disease in patients with potentially curable malignancies: a national registry dataset analysis. JACC CardioOncol. 4, 238–253 (2022).
Article PubMed PubMed Central Google Scholar
Florido, R. et al. Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk in Communities (ARIC) study. J. Am. Coll. Cardiol. 80, 22–32 (2022).
Article PubMed PubMed Central Google Scholar
Paterson, D. I. et al. Incident cardiovascular disease among adults with cancer. JACC CardioOncol. 4, 85–94 (2022).
Article PubMed PubMed Central Google Scholar
Zhang, X. et al. Ten-year cardiovascular risk among cancer survivors: the National Health and Nutrition Examination Survey. PLoS ONE 16, e0247919 (2021).
Article CAS PubMed PubMed Central Google Scholar
Aboumsallem, J. P., Moslehi, J. & de Boer, R. A. Reverse cardio-oncology: cancer development in patients with cardiovascular disease. J. Am. Heart Assoc. 9, e013754 (2020).
Article PubMed PubMed Central Google Scholar
Bell, C. F. et al. Risk of cancer after diagnosis of cardiovascular disease. JACC CardioOncol. 5, 431–440 (2023).
Article PubMed PubMed Central Google Scholar
Chianca, M. et al. Bidirectional relationship between cancer and heart failure: insights on circulating biomarkers. Front. Cardiovasc. Med. 9, 936654 (2022).
Article CAS PubMed PubMed Central Google Scholar
Hayek, S. S. et al. Preparing the cardiovascular workforce to care for oncology patients: JACC review topic of the week. J. Am. Coll. Cardiol. 73, 2226–2235 (2019).
Article PubMed PubMed Central Google Scholar
Herrmann, J. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat. Rev. Cardiol. 17, 474–502 (2020).
Article CAS PubMed PubMed Central Google Scholar
Herrmann, J. Vascular toxic effects of cancer therapies. Nat. Rev. Cardiol. 17, 503–522 (2020).
Article CAS PubMed PubMed Central Google Scholar
Omland, T., Heck, S. L. & Gulati, G. The role of cardioprotection in cancer therapy cardiotoxicity. JACC CardioOncol. 4, 19–37 (2022).
Article PubMed PubMed Central Google Scholar
Tan, S. et al. Immune checkpoint inhibitor therapy in oncology. JACC CardioOncol. 4, 579–597 (2022).
Article PubMed PubMed Central Google Scholar
Quartermaine, C. et al. Cardiovascular toxicities of BTK inhibitors in chronic lymphocytic leukemia. JACC CardioOncol. 5, 570–590 (2023).
Article PubMed PubMed Central Google Scholar
Glen, C. et al. Mechanistic and clinical overview cardiovascular toxicity of BRAF and MEK inhibitors: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 4, 1–18 (2022).
Article PubMed PubMed Central Google Scholar
Parashar, S. et al. Cancer treatment-related cardiovascular toxicity in gynecologic malignancies. JACC CardioOncol. 5, 159–173 (2023).
Article PubMed PubMed Central Google Scholar
Welty, N. E. & Gill, S. I. Cancer immunotherapy beyond checkpoint blockade. JACC CardioOncol. 4, 563–578 (2022).
Article PubMed PubMed Central Google Scholar
Georgiopoulos, G. et al. Cardiovascular toxicity of proteasome inhibitors: underlying mechanisms and management strategies: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 5, 1–21 (2023).
Article PubMed PubMed Central Google Scholar
Bergom, C. et al. Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification. JACC CardioOncol. 3, 343–359 (2021).
Article PubMed PubMed Central Google Scholar
de Boer, R. A. et al. Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur. J. Heart Fail. 22, 2272–2289 (2020).
Karlstaedt, A., Moslehi, J. & de Boer, R. A. Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer. Nat. Rev. Cardiol. 19, 414–425 (2022).
Article PubMed PubMed Central Google Scholar
Leiva, O. et al. Common pathophysiology in cancer, atrial fibrillation, atherosclerosis, and thrombosis: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 3, 619–634 (2021).
Article PubMed PubMed Central Google Scholar
Fuchs, F. D. & Whelton, P. K. High blood pressure and cardiovascular disease. Hypertension 75, 285–292 (2020).
Article CAS PubMed Google Scholar
Cohen, J. B. et al. Hypertension in cancer patients and survivors. JACC CardioOncol. 1, 238–251 (2019).
Article PubMed PubMed Central Google Scholar
Lewington, S. et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913 (2002).
Rahimi, K. et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet 397, 1625–1636 (2021).
Ettehad, D. et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387, 957–967 (2016).
Seretis, A. et al. Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies. Sci. Rep. 9, 8565 (2019).
Article PubMed PubMed Central Google Scholar
Harding, J. L. et al. Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts. J. Hypertens. 34, 149–155 (2016).
Article CAS PubMed Google Scholar
Han, H. et al. Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci. Rep. 7, 44877 (2017).
Article CAS PubMed PubMed Central Google Scholar
Nelson, R. H. Hyperlipidemia as a risk factor for cardiovascular disease. Prim. Care 40, 195–211 (2013).
Borén, J. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 41, 2313–2330 (2020).
Article PubMed PubMed Central Google Scholar
Lewington, S. et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370, 1829–1839 (2007).
Navarese, E. P. et al. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis. JAMA 319, 1566–1579 (2018).
留言 (0)